BioCentury
ARTICLE | Strategy

Innovators pick China

BeiGene teams Americans, Chinese returnees to develop cancer drugs in China

November 15, 2010 8:00 AM UTC

Five years after he co-founded BioDuro LLC, a contract research organization operating in China, John Oyler is at it again. But this time, his new team is doing what would have been almost unthinkable in China the first time around: They are starting a biotech company to discover and develop novel drugs.

The newco, called BeiGene Ltd., is headquartered in Beijing and will develop therapeutics for cancers that are prevalent in Asia...